Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer

Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer

Bibliographic Details
Main Authors: A. Necchi, D. Raggi, A. Briganti, E. Farè, P. Giannatempo, L. Marandino, A. Gallina, M. Colecchia, R. Lucianò, M. Bianchi, R. Colombo, A. Salonia, G. Gandaglia, N. Fossati, U. Capitanio, F. Montorsi, J. Boormans, Y. Liu, J. De Jong, R. Dittamore, E. Davicioni, P. Black, E. Gibb
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320326756

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320326756

Similar Items